undamentalytics Newsletter

Stem, Inc. key statistics and ratios

In fiscal 2025, Stem, Inc. had an operating margin of -35.6% and a current ratio of 0.91. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Stem, Inc.: financial ratios, annual
Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Gross margin−18.6%−10.8%1.0%9.1%0.8%−7.6%38.4%41.5%
Operating margin−272.6%−136.0%−65.2%−36.1%−38.9%−580.6%−35.6%−29.1%
Net margin−338.5%−430.0%−79.5%−34.2%−30.4%−590.7%88.2%−49.4%
Free-cash-flow margin−169.1%−92.8%−80.0%−29.6%−45.3%−25.5%4.4%7.9%
Return on equity——−41.3%−20.3%−28.7%———
Return on assets<−999%−151.5%−14.5%−9.5%−10.1%−95.2%36.9%−24.8%
Asset turnover69.370.350.180.280.330.160.420.50
Current ratio0.010.2611.642.001.881.060.910.83
Debt to equity——47.4%81.2%122.9%———
Interest cover (operating income ÷ interest)n/mn/mn/mn/mn/mn/mn/mn/m
Effective tax rate——————0.4%—
R&D as % of revenue83.8%43.9%17.8%10.6%12.2%35.5%22.6%18.2%
Capital spending as % of revenue0.0%0.0%0.5%0.4%0.3%0.2%0.0%0.0%
Free cash flow ÷ net income——————5.0%—

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

0 of 5 checks passed · June 30, 2026
What it owns · $280m
Short-term assets $89mLonger-term assets $190m
What it owes, and who funded it · $550m
Short-term liabilities $108mLonger-term liabilities $442mShareholders' equity $-270m
  • Short-term assets cover short-term liabilities $89m of assets due within a year against $108m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $89m short-term assets against $442m of longer-dated liabilities.
  • More cash than debt $38m of cash against $135m of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt $12m of operating cash flow against $135m of debt.
  • Operating profit covers interest at least five times over Operating income of −$43m against $30m of interest.

From Stem, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

0 /100

Weak moat

How hard Stem's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -5.4% of total assets over 5 years.

  • Pricing power 0 / 20

    Gross margin has been a median 7.4%, moving by 15.6 percentage points (standard deviation) across 6 years.

  • Durability 10 / 20

    Operating margin has been a median -75.5%; its worst year was -207.9%.

  • Cash conversion 2 / 20

    Free cash flow was positive in 1 of 6 years, at a median -35.5% of revenue.

AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (15 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: LGCL vs STEMSMRT vs STEMBBAI vs STEM

More: Application Software stocks compared, Technology sector, rankings of US companies

Figures from Stem, Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Stem, Inc.